56
Views
12
CrossRef citations to date
0
Altmetric
Review

The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics

Pages 2577-2591 | Published online: 30 Nov 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Patrizia Proia, Antonino Bianco, Gabriella Schiera, Patrizia Saladino, Valentina Contrò, Giovanni Caramazza, Marcello Traina, Keith A Grimaldi, Antonio Palma & Antonio Paoli. (2014) PPARα gene variants as predicted performance-enhancing polymorphisms in professional Italian soccer players. Open Access Journal of Sports Medicine 5, pages 273-278.
Read now

Articles from other publishers (11)

Antonio Paoli, Tatiana Moro, Gerardo Bosco, Antonino Bianco, Keith Grimaldi, Enrico Camporesi & Devanand Mangar. (2015) Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet. Marine Drugs 13:2, pages 996-1009.
Crossref
Sharon CresciJun WuMichael A. ProvinceJohn A. SpertusMichael SteffesJanet B. McGillEdwin L. AldermanMaria Mori BrooksSheryl F. KelseyRobert L. FryeRichard G. Bach. (2011) Peroxisome Proliferator-Activated Receptor Pathway Gene Polymorphism Associated With Extent of Coronary Artery Disease in Patients With Type 2 Diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial. Circulation 124:13, pages 1426-1434.
Crossref
Sreeja Purushothaman, V. K. Ajitkumar & R. Renuka Nair. (2011) Association of PPAR Intron 7 Polymorphism with Coronary Artery Disease: A Cross-Sectional Study . ISRN Cardiology 2011, pages 1-4.
Crossref
María Isabel Panadero, María del Carmen González, Emilio Herrera & Carlos Bocos. (2008) Modulación del PPARα por agentes farmacológicos y naturales y sus implicaciones metabólicas. Clínica e Investigación en Arteriosclerosis 20:6, pages 259-289.
Crossref
Sharon CresciPhilip G Jones, Carmen C Sucharov, Sharon MarshDavid E Lanfear, Adam GarsaMichael CourtoisCarla J WeinheimerJun WuMichael A ProvinceDaniel P KellyHoward L McLeod & John A Spertus. (2008) Interaction between PPARA genotype and β-blocker treatment influences clinical outcomes following acute coronary syndromes . Pharmacogenomics 9:10, pages 1403-1417.
Crossref
L. Gallicchio, Bindu Kalesan, Han-Yao Huang, Paul Strickland, Sandra C. Hoffman & Kathy J. Helzlsouer. (2008) Genetic Polymorphisms of Peroxisome Proliferator-Activated Receptors and the Risk of Cardiovascular Morbidity and Mortality in a Community-Based Cohort in Washington County, Maryland. PPAR Research 2008, pages 1-9.
Crossref
Gérard Siest, Hind Berrahmoune, Jean-Brice Marteau & Sophie Visvikis-Siest. 2008. Pharmacogenomics and Personalized Medicine. Pharmacogenomics and Personalized Medicine 413 446 .
Sharon Cresci. (2007) Pharmacogenetics of the PPAR genes and cardiovascular disease . Pharmacogenomics 8:11, pages 1581-1595.
Crossref
Christina L Aquilante. (2007) Pharmacogenetics of thiazolidinedione therapy. Pharmacogenomics 8:8, pages 917-931.
Crossref
Ondøřej Šeda & Lucie Šedová. (2007) Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and Type 2 diabetes. Pharmacogenomics 8:6, pages 587-596.
Crossref
Sharon Marsh, Derek J Van BoovenHoward L McLeod. (2006) Global pharmacogenetics: giving the genome to the masses. Pharmacogenomics 7:4, pages 625-631.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.